{"Title": "Lost in translation: Deciphering the mechanism of action of anti-human CTLA-4", "Year": 2019, "Source": "Clin. Cancer Res.", "Volume": "25", "Issue": 4, "Art.No": null, "PageStart": 1130, "PageEnd": 1132, "CitedBy": 8, "DOI": "10.1158/1078-0432.CCR-18-2509", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85056246481&origin=inward", "Abstract": "\u00a9 2018 American Association for Cancer Research.Despite a number of preclinical studies demonstrating that the activity of anti-CTLA-4 antibodies in murine models of cancer relies on effector T-cell activation and regulatory T cell depletion, the activity of the clinical antibodies remains controversial. To decipher such mechanisms is critical to the development of novel and more potent immunotherapies.", "AuthorKeywords": null, "IndexKeywords": ["Animals", "CTLA-4 Antigen", "Forkhead Transcription Factors", "Humans", "Immunotherapy", "Mice", "Neoplasms", "T-Lymphocytes, Regulatory"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85056246481", "SubjectAreas": [["Oncology", "MEDI", "2730"], ["Cancer Research", "BIOC", "1306"]], "AuthorData": {"57205358086": {"Name": "Quezada S.", "AuthorID": "57205358086", "AffiliationID": "60022148", "AffiliationName": "Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute"}, "35416735200": {"Name": "Peggs K.", "AuthorID": "35416735200", "AffiliationID": "60022148", "AffiliationName": "Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute"}}}